The effect of osteoporosis drug against bone remodeling around femoral implant after total hip arthroplasty
Not Applicable
- Conditions
- hip osetoarthritis Osteoporosis
- Registration Number
- JPRN-UMIN000020381
- Lead Sponsor
- Mie University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)hypocalcemia 2)hypercalcemia 3)patients who are allergic to the study drug 4)patients who had liver dysfunction or renal dysfunction 5)patients who fractured in surgery 6)patients who has been determined to be inappropriate by Officer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method % change in bone mineral density in zone 7 based on zones of Gruen et al. at 12 months after cementless total hip arthroplasty in groups treated denosumab therapy compared the control groups.
- Secondary Outcome Measures
Name Time Method